Related Experiment Video
Updated: Dec 25, 2025
05:23
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
1.5K
Tracking cancer progression: from circulating tumor cells to metastasis
Francesc Castro-Giner1,2, Nicola Aceto3
1Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, 4058, Basel, Switzerland.
Genome Medicine
|March 21, 2020
Summary
Circulating tumor cells (CTCs) offer insights into metastatic cancer biology and personalized treatment via liquid biopsy. While challenging for early detection, CTC analysis aids in monitoring disease progression and guiding precision medicine.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Circulating tumor cells (CTCs) are crucial for understanding metastatic cancer biology.
- Liquid biopsy approaches using CTCs show promise for personalized cancer treatment and monitoring.
- CTCs are heterogeneous and play a key role in metastasis initiation and progression.
Purpose of the Study:
- To review current data on CTC biology and clinical applications.
- To highlight the strengths, challenges, and opportunities of liquid biopsy.
- To discuss the impact of CTC analysis on understanding metastasis and guiding precision medicine.
Main Methods:
- Review of recent studies on CTC biology and clinical applications.
- Analysis of single-cell-resolution genomics and transcriptomics data.
- Evaluation of CTC enumeration and molecular analysis for clinical utility.
Main Results:
- CTCs exhibit significant heterogeneity, with a subset capable of initiating metastasis.
- CTCs employ mechanisms like clustering and cell interactions to enhance metastatic potential.
- CTC enumeration and molecular analysis show potential for monitoring cancer progression and informing treatment decisions.
Conclusions:
- CTC analysis provides valuable insights into metastatic cancer biology.
- Liquid biopsy using CTCs is a promising tool for personalized cancer treatment and precision medicine.
- While challenging for early detection, CTCs are vital for monitoring disease and guiding therapy.
Related Concept Videos
02:30Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
02:07Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K